Researchers at UTHealth Houston have been awarded an $8.1 million grant by the National Institutes of Health (NIH) to examine skeletal stem cells as potential drivers of craniofacial bone diseases and ...
A research team evaluated the treatment outcomes for discoid lateral meniscus (DLM) with osteochondritis dissecans. Age was found to be a risk factor for osteochondritis dissecans relapse or ...
Sparta has developed a first-of-its-kind device, Ormi ™, to treat knee osteoarthritis.The US FDA granted Ormi Breakthrough Device Designation. The impact of knee osteoarthritis cannot be ignored ...